| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data
|
Koh, Young Wha
|
|
2019
|
145 |
6 |
p. 1427-1436
|
artikel
|
| 2 |
Alternative and canonical NF-kB pathways DNA-binding hierarchies networks define Hodgkin lymphoma and Non-Hodgkin diffuse large B Cell lymphoma respectively
|
Gamboa-Cedeño, Angélica María
|
|
2019
|
145 |
6 |
p. 1437-1448
|
artikel
|
| 3 |
Beyond a chemopreventive reagent, aspirin is a master regulator of the hallmarks of cancer
|
Zhang, Xiao
|
|
2019
|
145 |
6 |
p. 1387-1403
|
artikel
|
| 4 |
Chemopreventive effect of Callistemon citrinus (Curtis) Skeels against colon cancer induced by 1,2-dimethylhydrazine in rats
|
López-Mejia, Alejandro
|
|
2019
|
145 |
6 |
p. 1417-1426
|
artikel
|
| 5 |
Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer
|
Hawkins, Peter G.
|
|
2019
|
145 |
6 |
p. 1635-1643
|
artikel
|
| 6 |
Clinical impact of PD-L1 and PD-1 expression in squamous cell cancer of the vulva
|
Thangarajah, Fabinshy
|
|
2019
|
145 |
6 |
p. 1651-1660
|
artikel
|
| 7 |
Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma
|
Gupta, Nidhi
|
|
2019
|
145 |
6 |
p. 1601-1611
|
artikel
|
| 8 |
Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice
|
Ahn, Beung-Chul
|
|
2019
|
145 |
6 |
p. 1613-1623
|
artikel
|
| 9 |
Different statistical techniques dealing with confounding in observational research: measuring the effect of breast-conserving therapy and mastectomy on survival
|
Maaren, Marissa C. van
|
|
2019
|
145 |
6 |
p. 1485-1493
|
artikel
|
| 10 |
First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression
|
Schuler, Martin
|
|
2019
|
145 |
6 |
p. 1569-1579
|
artikel
|
| 11 |
Focal adhesion kinase (FAK) phosphorylation is a key regulator of embryonal rhabdomyosarcoma (ERMS) cell viability and migration
|
Al-Ghabkari, Abdulhameed
|
|
2019
|
145 |
6 |
p. 1461-1469
|
artikel
|
| 12 |
Gastrointestinal stromal tumors (GISTs) with remarkable cystic change: a specific subtype of GISTs with relatively indolent behaviors and favorable prognoses
|
Xue, Anwei
|
|
2019
|
145 |
6 |
p. 1559-1568
|
artikel
|
| 13 |
IL-6 signaling contributes to radioresistance of prostate cancer through key DNA repair-associated molecules ATM, ATR, and BRCA 1/2
|
Chen, Xiaodong
|
|
2019
|
145 |
6 |
p. 1471-1484
|
artikel
|
| 14 |
Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases
|
Atallah-Yunes, Suheil Albert
|
|
2019
|
145 |
6 |
p. 1527-1557
|
artikel
|
| 15 |
Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancer
|
Lian, Fan
|
|
2019
|
145 |
6 |
p. 1625-1633
|
artikel
|
| 16 |
Molecular and cellular adaptations to exercise training in skeletal muscle from cancer patients treated with chemotherapy
|
Møller, Andreas Buch
|
|
2019
|
145 |
6 |
p. 1449-1460
|
artikel
|
| 17 |
NOD1 and NOD2 of the innate immune system is differently expressed in human clear cell renal cell carcinoma, corresponding healthy renal tissue, its vasculature and primary isolated renal tubular epithelial cells
|
Mey, Lilli
|
|
2019
|
145 |
6 |
p. 1405-1416
|
artikel
|
| 18 |
Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia
|
Cortes, Jorge E.
|
|
2019
|
145 |
6 |
p. 1589-1599
|
artikel
|
| 19 |
Research driving innovation: what are key factors for successful integration of translational science into oncology care concepts? 5th European Roundtable Meeting (ERTM) May 4th, 2018, Berlin, Germany
|
Ortmann, Olaf
|
|
2019
|
145 |
6 |
p. 1521-1525
|
artikel
|
| 20 |
Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry)
|
Möbius, Susanne
|
|
2019
|
145 |
6 |
p. 1645-1650
|
artikel
|
| 21 |
Serum PD-1 levels measured by ELISA using Nivolumab increased in advanced RCC patients: novel approach to develop companion diagnostics for antibody therapy
|
Mizutani, Kosuke
|
|
2018
|
145 |
6 |
p. 1661-1663
|
artikel
|
| 22 |
The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy
|
Skaga, Erlend
|
|
2019
|
145 |
6 |
p. 1495-1507
|
artikel
|
| 23 |
The role of PD-1/PD-L1 axis and macrophage in the progression and treatment of cancer
|
Cai, Jiajing
|
|
2019
|
145 |
6 |
p. 1377-1385
|
artikel
|
| 24 |
TPP1 OB-fold domain protein suppresses cell proliferation and induces cell apoptosis by inhibiting telomerase recruitment to telomeres in human lung cancer cells
|
Zhu, Jinfang
|
|
2019
|
145 |
6 |
p. 1509-1519
|
artikel
|
| 25 |
Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter?
|
Achard, Vérane
|
|
2019
|
145 |
6 |
p. 1581-1588
|
artikel
|
Tijdschrift beschrijving